Connection
Amy Keating to Quinolines
This is a "connection" page, showing publications Amy Keating has written about Quinolines.
|
|
Connection Strength |
|
 |
|
 |
|
0.483 |
|
|
|
-
Knubel KH, Pernu BM, Sufit A, Nelson S, Pierce AM, Keating AK. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme. Oncotarget. 2014 Mar 15; 5(5):1338-51.
Score: 0.483